In fact, double-knockouts of HRAS and NRAS display a RASopathy-like phenotype [77], which contrasts to the assessment of the same double-knockout 25 years ago [75], i.e. at a time when many other RAS knockout studies were conducted and evaluated. The gene discussed is HRAS; the disease is RASopathy.